Part,  Chapter, Paragraph

1    I,     2. 10.  2|            conjugates may allow some tumour targeting; and~- Metallic
2   II,     5.  6.  3|     spondyloarthropathy, fracture or tumour. Such specific causes account
3   II,     5.  8.  3|           cerebral stroke, malignant tumour.~ ~An increased incidence
4  III,    10.  2.  4|              between polymorphism of tumour necrosis factor alpha-308
5  III,    10.  3.  1|              increased risk of brain tumour or acoustic neuroma. For
6  III,    10.  3.  1|            an association. Risk of a tumour on the same side of the
7   IV,    11.  5.  3|             Ag-HIV).~With respect to tumour markers carried out for
8   IV,    11.  5.  3|       routine basis.~ ~Figure 11.17. Tumour markers in organs transplants
9  Key,   Ap5.  0.  0| triglycerides~tuberculosis~tularemia~tumour~tumours~turbinate~Turkey~